Use of milnacipran in patients suffering from poststroke depression

Arora, Hobinder; Kaur, Rajdeep

doi:10.4103/0019-5545.55099

Cited by 4 publications

(4 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[1–18] Studies done in the 1960s evaluated the efficacy of tricyclic antidepressants. Later studies have evaluated the efficacy of nitroxazepine, centpropazine, amineptine, tianeptine, sertraline and milnacipran.…”

Section: Introductionmentioning

confidence: 99%

“…A total of 18 open trials without a comparator group have been conducted to evaluate the efficacy of various antidepressants [ Table 1 ]. [ 1 – 18 ] Studies done in the 1960s evaluated the efficacy of tricyclic antidepressants. Later studies have evaluated the efficacy of nitroxazepine, centpropazine, amineptine, tianeptine, sertraline and milnacipran.…”

Section: Introductionmentioning

confidence: 99%

“…[ 13 ] A recently published trial, which evaluated the efficacy of milnacipran, included subjects who had suffered from stroke. [ 18 ] It is also one of the few trials which have included subjects more than 65 years of age. The trial done by Margoob et al .…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Research on antidepressants in India

Grover

Aggarwal

2010

Indian J Psychiatry

View full text Add to dashboard Cite

Data suggests that antidepressants are useful in the management of depressive disorders, anxiety disorders, sexual dysfunction, eating disorders, impulse control disorders, enuresis, aggression and some personality disorders. Research focusing on the usefulness of antidepressants in India has more or less followed the trends seen in the West. Most of the studies conducted in India have evaluated various antidepressants in depression. In this article, we review studies conducted in India on various antidepressants. The data suggests that antidepressants have been evaluated mainly in the acute phase treatment and rare studies have evaluated the efficacy in continuation phase treatment.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Research on antidepressants in India

Grover

Aggarwal

2010

Indian J Psychiatry

View full text Add to dashboard Cite

show abstract

“…Tegegne et al (2015) reported a prevalence rate of 33.5% for anxiety and 32.8% for depression, among persons with epilepsy. Arora and Kaur (2009) also revealed the prevalence of depression among patients with epilepsy, which was found to be 25%. Gilliam and Kanner (2002) found that anxiety and depression were highly prevalent in the population with epilepsy and were the most common comorbid psychiatric disorders in patients with epilepsy.…”

Section: Discussionmentioning

confidence: 92%

Perceived Stigma and Its Association With Stress, Anxiety, and Depression Among Patients With Epilepsy

Ranjan¹,

Gupta²,

Srivastava

2021

J Nerv Ment Dis

View full text Add to dashboard Cite

The present study focuses on exploring the prevalence and relationship of stigma, stress, anxiety, and depression among patients with epilepsy. This hospital-based study consisted of 200 patients diagnosed with epilepsy using a purposive sampling selected from the outpatient department of the Central Indian Institute of Mental Health and Neuro Sciences, Dewada, Chhattisgarh, India. Patients were assessed through a sociodemographic datasheet, Stigma Scale of Epilepsy, and Depression Anxiety Stress Scales. The result of the study reveals that patient with epilepsy perceived 25% of high stigma 61.0% of stress, 55.0% of anxiety, and 47.5% of the extremely severe level depression. In regression analysis, overall perceived stigma strongly contributes 32.9% to the variance on stress, anxiety, and depression in epileptic patients. The present study helps mental health professionals to understand the problems faced by patients with epilepsy and to create awareness about the same in society so that patients diagnosed with epilepsy are not ostracized.

show abstract